Align Technology | ALGN - Sales Revenues


Align Technology reported $1.06B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
3M USD 6.5B 500M Jun/2026
Align Technology USD 1.06B 20M Jun/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Bruker USD 838.5M 15.1M Jun/2026
Cardinal Health USD 60.9B 4.73B Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cooper Companies USD 1.08B 57.4M Mar/2026
CVS Health USD 100.4B 5.3B Mar/2026
Danaher USD 6.3B 350M Jun/2026
Dentsply International USD 880M 81M Mar/2026
Dexcom USD 1.31B 120M Jun/2026
Henry Schein USD 3.46B 90M Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
IQVIA Holdings USD 4.37B 220M Jun/2026
McKesson USD 92.3B 13.86B Mar/2026
Mettler Toledo International USD 1.03B 82.87M Jun/2026
Revvity USD 729.68M 18.68M Jun/2026
Solventum Corp USD 2.01B 20M Mar/2026
Stryker USD 6.6B 600M Jun/2026
Teleflex USD 548.3M 20.68M Mar/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Veeva Systems USD 882.95M 47M Mar/2026
Waters USD 1.64B 370M Jun/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026
Zoetis USD 2.3B 100M Mar/2026